AllSight
Companies · QTTB · Pharmaceutical Preparations

Q32 Bio Inc. (QTTB)

Q32 Bio Inc. (QTTB) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Q32 Bio Inc. (QTTB) stock — financials & valuation

Key numbers for Q32 Bio Inc. (QTTB): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 63/100 — a percentile rank of Q32 Bio Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$284.6M
P / E8.4×
P / S5.3×
EV / EBITDA8.2×
Gross margin100.0%
Operating margin39.9%
Net margin62.9%
Return on equity31.9%
ROIC-5880.0%
Debt / equity0.0×
Dividend yield0.0%

Independent of the events above — derived from Q32 Bio Inc.’s own financial statements and shown as context, never as advice.

Sep 14, 2026Two C-suite hires
Q32 Bio adds late-stage CMO and CDO as pivotal planning nears
Aug 5, 2026
Loss beat estimates; pipeline timetable and post-raise runway were reaffirmed.
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact